MarketLens

Is GSK's Global Health Focus a Smart Investment Strategy

3 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Why Are Dividend Growth Stocks Back in Focus for 2026

5 months ago

Is JD.com's Debt Strategy a Smart Move Amidst Global Rate Hikes

4 months ago

What is Stance Capital's Investment Strategy for 2026

4 months ago

What is the Significance of Lynavoy's FDA Approval for GSK

2 months ago

GSK India first-quarter profit rises on steady vaccine demand

GSK India's first-quarter profit rose 15.7%, aided by steady demand across its vaccine and drug portfolio, including respiratory and specialty medicines.

GSK

Stock News•3 weeks ago

GSK Launches Cost-Saving Plan to Accelerate Drug Pipeline

GSK targets $2.52B in annual savings by 2029 under CEO Luke Miels' roadmap to accelerate its drug pipeline and hit 2031 sales targets.

GSK

Stock News•2 months ago

GSK plc (GSK) Discusses Bepirovirsen Phase III Data and Advances in Hepatitis B Treatment Transcript

GSK plc is advancing its Phase III clinical program for bepirovirsen, a potential treatment for chronic hepatitis B. The company is currently evaluating trial data to determine the drug's efficacy and...

GSK

Stock News•3 months ago

Here's Why GSK (GSK) is a Strong Value Stock

GSK (GSK) is currently highlighted as a potential value stock opportunity by Zacks Premium research. The analysis utilizes proprietary Style Scores to categorize the company's investment profile for v...

GSK